Out-licensing

We are eager to out-license our Nuntius biotechnology to mRNA players for the development of mRNA vaccines and therapies.

Last news

soiree-laureats

Réseau entreprendre Auvergne celebrates its new Laureates

posted June 20, 2016

“Réseau entreprendre Auvergne celebrates its ...Read More

Recent Search Keywords